LNAI
Lunai Bioworks Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.39
+1.70%Margins
Gross margin
-360.7%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
1342.8%
Return on equity
-1301.0%
Return on assets
120.9%
Return on invested capital
0.00x
Asset turnover
-$5.3M
Cash from operations
$0.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026